Cipro showed a consistent upregulation of IL-6 production of splenocytes in response to B- or T-cell mitogens, and this may be of benefit in chemotherapy-related sepsis as low Il-6 production from systemic immune compartments correlates with sepsis mortality (Adamik et al, 1997). The gene discussed is IL6; the disease is Sepsis.